Mesenchymal Stem Cell Therapy for Psoriasis: A New Treatment Approach

A 47-year-old man with 25 years of psoriasis finds relief through an innovative treatment using umbilical cord stem cells.

Psoriasis is a chronic autoimmune skin condition affecting approximately 2% of the global population. Living with psoriasis can be a constant challenge. This autoimmune disease causes red, itchy, and scaly skin, making life uncomfortable for millions. Traditional treatments often fall short, but a new therapy using stem cells derived from umbilical cord tissue offers new hope.

In a recent case study, a 47-year-old man with a 25-year history of psoriasis tried a new therapy after finding little success with numerous prior treatments. This innovative approach used minimally processed umbilical cord-derived stem cells. These cells, known for reducing inflammation and repairing damaged tissues, were delivered through three targeted injections over two weeks. The results were remarkable:

• Red, scaly patches began to fade within days.
• His skin cleared completely within four months.
• No side effects or recurrence were reported during a five-month follow-up.

Stem cells act as the body’s natural repair system, reducing inflammation and promoting healing. Umbilical cord-derived stem cells are ethically sourced and provide a safe, powerful option for tackling autoimmune conditions like psoriasis.

This case study highlights the potential of umbilical cord stem cell therapy to revolutionize psoriasis treatment, it offers a glimpse into a future where psoriasis relief is more accessible and effective. These findings provide new hope for those who struggle with this chronic condition, offering lasting solutions and improved quality of life.

References

Ahn, S. Y. Lee, W.-J. Jung, J. Pi, and K.-H. Lee, ‘Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report’, World J Clin Cases, vol. 9, no. 23, pp. 6798–6803, Aug. 2021, doi: 10.12998/wjcc.v9.i23.6798.